Clinical and serological features of patients with autoantibodies to GW/P bodies
- 17 September 2007
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 125 (3) , 247-256
- https://doi.org/10.1016/j.clim.2007.07.016
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Probing the mRNA processing body using protein macroarrays and "autoantigenomics"RNA, 2007
- Illuminating the silence: understanding the structure and function of small RNAsNature Reviews Molecular Cell Biology, 2007
- Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibodyJournal of Immunological Methods, 2006
- mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexesGenes & Development, 2006
- Processing body autoantibodies reconsideredRNA, 2006
- RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies and stress granulesRNA, 2006
- The RNA interference pathway: a new target for autoimmunityArthritis Research & Therapy, 2006
- Ge-1 is a central component of the mammalian cytoplasmic mRNA processing bodyRNA, 2005
- A Panel of Monoclonal Antibodies to Cytoplasmic GW Bodies and the mRNA Binding Protein GW182Hybridoma and Hybridomics, 2003
- The Immunoreactive Region in a Novel Autoantigen Contains a Nuclear Localization SequenceClinical Immunology and Immunopathology, 1994